Industry News
Pharmaceutical Industry News
With a new, patient-friendly route…
With a new, patient-friendly route of administration, Amgen may have found a way to increase demand for Tepezza. A phase 3 trial of patients with thyroid eye disease has shown that subcutaneous injection of Tepezza
Eli Lilly has published a video…
Eli Lilly has published a video about how medicines affect lives to mark its 150th anniversary and the arrival of college basketball stars in its home city.
VML Health has published a report…
VML Health has published a report about 10 trends defining the future of healthcare, making the case that pharma marketers must adapt to patients shifting their goals from lifespan to “joyspan.”
In a flurry of activity, biopharma…
In a flurry of activity, biopharma companies pulled off seven transactions in the last two weeks of March worth a combined $29 billion. The blitz indicates that 2026 will be a prime year for M&A
After shedding expensive…
After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its Matrix-M vaccine adjuvant as a versatile, license-ready asset for other biopharma companies like Sanofi and Pfizer.
How Pam Bondi Got Fired, and a Flood of Deadly New Drugs
Plus, your Friday news quiz.
Where does pharma’s reshoring…
Where does pharma’s reshoring push stand today, and what comes next? Reshoring Institute Executive Director Rosemary Coates explains the industry’s unique advantage and the hurdles still in the way.
Trump Revamps Metal and Pharmaceutical Tariffs
The administration announced new levies and made changes to existing tariffs for industries that have proved influential on the president’s trade policy.
E.P.A. Targets Microplastics and Drugs in Drinking Water
The move drew praise from leaders of the Make America Healthy Again movement who had recently criticized the agency’s handling of toxic chemicals.
The U.S. will impose a 100% tariff…
The U.S. will impose a 100% tariff on drug imports with some exceptions. Takeda plans to cut 634 jobs in the U.S. as part of its $1.26 billion savings plan. Eli Lilly deepened its relationship
The president has rolled out a…
The president has rolled out a 100% tariff rate on patented pharmaceutical products and ingredients following a "Section 232" investigation, according to a White House fact sheet.
The U.K.’s end of the deal…
The U.K.'s end of the deal requires it to spend more on drugs through its National Health Service, which it is implementing through a higher cost-effectiveness threshold for its National Institute for Health and Care
BioNTech is turning out the lights…
BioNTech is turning out the lights at the Singapore plant it purchased from Novartis at the height of the COVID-19 outbreak, reflecting a sharp reversal in the mRNA specialist’s trajectory since the pandemic’s end.
A year after revealing his…
A year after revealing his “Liberation Day” trade policy initiatives, U.S. President Donald Trump is set to announce tariffs of 100% on some pharmaceutical products imported from outside the country, Bloomberg reports, citing unidentified sources
As the battle for the weight-loss…
As the battle for the weight-loss market expands to oral drugs, analysts are already predicting a blockbuster rollout of Lilly's Foundayo, while Novo is aggressively touting superior weight-loss data for its Wegovy pill to protect
A Belgian court ordered Poland and…
A Belgian court ordered Poland and Romania to pay Pfizer for COVID vaccines after the countries had attempted to get out of Europe's massive vaccine procurement deal.
Another green light appears…
Another green light appears increasingly within reach for AstraZeneca’s Emerald program after a combo regimen featuring the company’s immunotherapy duo, Imfinzi and Imjudo, showed a progression-free survival benefit in patients with locoregional liver cancer.
How A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company
Who needs more than two employees when artificial intelligence can do so many corporate tasks? It’s super efficient — and a little bit lonely.
Adragos Pharma, a German CDMO,…
Adragos Pharma, a German CDMO, snapped up one of Europe’s largest sterile injectables production plants for an undisclosed price from Sanofi.
Six years after signing a U.S….
Six years after signing a U.S. marketing partnership with Hikma Pharma for its seasonal allergy spray Ryaltris, India’s Glenmark is now going it alone.